The inhibition of FTO expression notably led to increased proliferation rates and heightened resistance to chemotherapeutic agents like CDDP and PPARi in A2780 ovarian cancer cells, alongside a decrease in apoptotic activity. The gene discussed is FTO; the disease is ovarian cancer.